Author Archives: NYT > Health

Vital Signs: Nostrums: A Bit of Marijuana Is Found to Ease Pain

Patients with persistent nerve damage inhaled, and felt better, but did not get high, a Canadian study reports. (Source: NYT Health)

Topical Gel Catches Up With Pills for Relief

Controlled trials suggest that a topical nonsteroidal anti-inflammatory drug in a cream is as effective as their oral counterparts for treating osteoarthritis, soreness and tendinitis. (Source: NYT Health)

Botox Maker Settles Case

Allergan agreed to pay $600 million to settle criminal and civil allegations that it had marketed Botox for medical uses, like pain and headache, not approved by the Food and Drug Administration. (Source: NYT Health)

Where It Hurts

An expansive mix of medical reportage, history and memoir explores our relationship to pain. (Source: NYT Health)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Estimate Lowered of Typical Flu Toll

The Centers for Disease Control and Prevention substantially lowered its often-quoted estimate of how many people die in a typical flu season, to 24,000 from 36,000. (Source: NYT Health)

Lilly Moves Closer to Approval to Market Cymbalta for Chronic Pain

An advisory panel to the Food and Drug Administration voted 8-6 to expand approved uses of Cymbalta. (Source: NYT Health)

Books of The Times: Living With the Aches That Won’t Go Away

Melanie Thernstrom combines memoir, scholarly research, and journalistic reportage to write about pain and its management. (Source: NYT Health)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Cymbalta Nears Approval for Use on Chronic Pain

An advisory panel to the Food and Drug Administration voted 8-6 to expand approved uses of Cymbalta. (Source: NYT Health)

Books of The Times: Melanie Thernstrom’s ‘Pain Chronicles’: The Cures and the Myths

Melanie Thernstrom combines memoir, scholarly research, and journalistic reportage to write about pain and its management. (Source: NYT Health)

F.D.A. Panel Approves Use of Antidepressant for Pain

An advisory committee votes to allow Eli Lilly to market Cymbalta for chronic pain, especially back ailments. (Source: NYT Health)